Interpace Biosciences
Why Robinhood?
You can watch IDXG and buy or sell other stocks, ETFs, and their options commission-free!About IDXG
Interpace Biosciences, Inc. operates as an bioinformatics company, which engages in the development and commercialization of molecular diagnostic test and pathology services. It offers PancraGEN, a pancreatic cyst and pancreaticobiliary solid lesion molecular test that can aid in pancreatic cyst diagnosis and pancreatic cancer risk assessment; ThyGenX and PathFinderTG which assesses thyroid nodules for risk of malignancy; and ThyraMIR, which assesses thyroid nodules for risk of malignancy utilizing a proprietary gene expression assay.
IDXG Key Statistics
Stock Snapshot
With a market cap of 70.66M, Interpace Biosciences(IDXG) trades at $1.85. The stock has a price-to-earnings ratio of 0.00 and currently yields dividends of 0.0%.
As of 2026-04-01, Interpace Biosciences(IDXG) stock has fluctuated between $1.84 and $1.90. The current price stands at $1.85, placing the stock +0.5% above today's low and -2.6% off the high.
The Interpace Biosciences(IDXG)'s current trading volume is 208, compared to an average daily volume of 573.44K.
In the last year, Interpace Biosciences(IDXG) shares hit a 52-week high of $1.90 and a 52-week low of $0.38.
In the last year, Interpace Biosciences(IDXG) shares hit a 52-week high of $1.90 and a 52-week low of $0.38.
Analyst ratings
100%
of 6 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.